vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and FIRST INTERSTATE BANCSYSTEM INC (FIBK). Click either name above to swap in a different company.
FIRST INTERSTATE BANCSYSTEM INC is the larger business by last-quarter revenue ($313.0M vs $168.4M, roughly 1.9× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 19.8%). Over the past eight quarters, FIRST INTERSTATE BANCSYSTEM INC's revenue compounded faster (13.7% CAGR vs 10.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
First Interstate BancSystem, Inc. is a financial holding company headquartered in Billings, Montana. It is the parent company of First Interstate Bank, a community bank with locations throughout 14 states within the Western and Midwestern United States. It is the largest bank based in Montana, as measured by total assets.
ESPR vs FIBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $313.0M |
| Net Profit | — | $108.8M |
| Gross Margin | — | — |
| Operating Margin | 50.6% | 44.5% |
| Net Margin | — | 34.8% |
| Revenue YoY | 143.7% | 19.8% |
| Net Profit YoY | — | 108.8% |
| EPS (diluted) | $0.32 | $1.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $313.0M | ||
| Q3 25 | $87.3M | $250.5M | ||
| Q2 25 | $82.4M | $248.3M | ||
| Q1 25 | $65.0M | $247.0M | ||
| Q4 24 | $69.1M | $261.3M | ||
| Q3 24 | $51.6M | $251.9M | ||
| Q2 24 | $73.8M | $244.3M | ||
| Q1 24 | $137.7M | $242.2M |
| Q4 25 | — | $108.8M | ||
| Q3 25 | $-31.3M | $71.4M | ||
| Q2 25 | $-12.7M | $71.7M | ||
| Q1 25 | $-40.5M | $50.2M | ||
| Q4 24 | — | $52.1M | ||
| Q3 24 | $-29.5M | $55.5M | ||
| Q2 24 | $-61.9M | $60.0M | ||
| Q1 24 | $61.0M | $58.4M |
| Q4 25 | 50.6% | 44.5% | ||
| Q3 25 | -11.4% | 37.0% | ||
| Q2 25 | 8.6% | 37.7% | ||
| Q1 25 | -34.0% | 26.9% | ||
| Q4 24 | -6.4% | 25.5% | ||
| Q3 24 | -31.0% | 28.9% | ||
| Q2 24 | 3.5% | 32.1% | ||
| Q1 24 | 52.5% | 31.7% |
| Q4 25 | — | 34.8% | ||
| Q3 25 | -35.9% | 28.5% | ||
| Q2 25 | -15.4% | 28.9% | ||
| Q1 25 | -62.2% | 20.3% | ||
| Q4 24 | — | 19.9% | ||
| Q3 24 | -57.2% | 22.0% | ||
| Q2 24 | -83.9% | 24.6% | ||
| Q1 24 | 44.3% | 24.1% |
| Q4 25 | $0.32 | $1.07 | ||
| Q3 25 | $-0.16 | $0.69 | ||
| Q2 25 | $-0.06 | $0.69 | ||
| Q1 25 | $-0.21 | $0.49 | ||
| Q4 24 | $-0.14 | $0.50 | ||
| Q3 24 | $-0.15 | $0.54 | ||
| Q2 24 | $-0.33 | $0.58 | ||
| Q1 24 | $0.34 | $0.57 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | — |
| Total DebtLower is stronger | — | $146.3M |
| Stockholders' EquityBook value | $-302.0M | $3.4B |
| Total Assets | $465.9M | $26.6B |
| Debt / EquityLower = less leverage | — | 0.04× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | — | ||
| Q3 25 | $92.4M | — | ||
| Q2 25 | $86.1M | — | ||
| Q1 25 | $114.6M | — | ||
| Q4 24 | $144.8M | — | ||
| Q3 24 | $144.7M | — | ||
| Q2 24 | $189.3M | — | ||
| Q1 24 | $226.6M | — |
| Q4 25 | — | $146.3M | ||
| Q3 25 | — | $146.2M | ||
| Q2 25 | — | $252.0M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $132.2M | ||
| Q3 24 | — | $137.3M | ||
| Q2 24 | — | $383.4M | ||
| Q1 24 | — | $370.8M |
| Q4 25 | $-302.0M | $3.4B | ||
| Q3 25 | $-451.4M | $3.4B | ||
| Q2 25 | $-433.5M | $3.4B | ||
| Q1 25 | $-426.2M | $3.4B | ||
| Q4 24 | $-388.7M | $3.3B | ||
| Q3 24 | $-370.2M | $3.4B | ||
| Q2 24 | $-344.2M | $3.2B | ||
| Q1 24 | $-294.3M | $3.2B |
| Q4 25 | $465.9M | $26.6B | ||
| Q3 25 | $364.0M | $27.3B | ||
| Q2 25 | $347.1M | $27.6B | ||
| Q1 25 | $324.0M | $28.3B | ||
| Q4 24 | $343.8M | $29.1B | ||
| Q3 24 | $314.1M | $29.6B | ||
| Q2 24 | $352.3M | $30.3B | ||
| Q1 24 | $373.1M | $30.1B |
| Q4 25 | — | 0.04× | ||
| Q3 25 | — | 0.04× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.04× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.12× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $305.6M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | 2.81× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $305.6M | ||
| Q3 25 | $-4.3M | $91.7M | ||
| Q2 25 | $-31.4M | $68.1M | ||
| Q1 25 | $-22.6M | $78.5M | ||
| Q4 24 | $-35.0M | $355.0M | ||
| Q3 24 | $-35.3M | $89.9M | ||
| Q2 24 | $-7.2M | $82.3M | ||
| Q1 24 | $53.8M | $87.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-35.5M | — | ||
| Q2 24 | $-7.3M | — | ||
| Q1 24 | $53.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -68.7% | — | ||
| Q2 24 | -9.9% | — | ||
| Q1 24 | 39.0% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | 2.81× | ||
| Q3 25 | — | 1.28× | ||
| Q2 25 | — | 0.95× | ||
| Q1 25 | — | 1.56× | ||
| Q4 24 | — | 6.81× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | 1.37× | ||
| Q1 24 | 0.88× | 1.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
FIBK
Segment breakdown not available.
